Microscopic drug particles target Hard-to-Treat abdominal cancers in early trial
NCT ID NCT05159050
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested a new way to deliver chemotherapy directly into the abdomen for people with advanced cancers that have spread to the lining of the belly. The treatment uses tiny particles loaded with paclitaxel, a standard chemo drug, to better target tumors. Only 4 people participated before the study ended, and the main goals were to check safety and find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States